BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15914279)

  • 1. Diagnostic usefulness of PCR profiling of the differentially expressed marker genes in thyroid papillary carcinomas.
    Hamada A; Mankovskaya S; Saenko V; Rogounovitch T; Mine M; Namba H; Nakashima M; Demidchik Y; Demidchik E; Yamashita S
    Cancer Lett; 2005 Jun; 224(2):289-301. PubMed ID: 15914279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.
    Pizzolanti G; Russo L; Richiusa P; Bronte V; Nuara RB; Rodolico V; Amato MC; Smeraldi L; Sisto PS; Nucera M; Bommarito A; Citarrella R; Lo Coco R; Cabibi D; Lo Coco A; Frasca F; Gulotta G; Latteri MA; Modica G; Galluzzo A; Giordano C
    Thyroid; 2007 Nov; 17(11):1109-15. PubMed ID: 17727338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
    Murphy KM; Chen F; Clark DP
    Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
    Finley DJ; Arora N; Zhu B; Gallagher L; Fahey TJ
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma.
    Hawthorn L; Stein L; Varma R; Wiseman S; Loree T; Tan D
    Head Neck; 2004 Dec; 26(12):1069-83. PubMed ID: 15515157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.
    Zatelli MC; Trasforini G; Leoni S; Frigato G; Buratto M; Tagliati F; Rossi R; Cavazzini L; Roti E; degli Uberti EC
    Eur J Endocrinol; 2009 Sep; 161(3):467-73. PubMed ID: 19574281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
    Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.
    Jarzab B; Wiench M; Fujarewicz K; Simek K; Jarzab M; Oczko-Wojciechowska M; Wloch J; Czarniecka A; Chmielik E; Lange D; Pawlaczek A; Szpak S; Gubala E; Swierniak A
    Cancer Res; 2005 Feb; 65(4):1587-97. PubMed ID: 15735049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.
    Cañadas-Garre M; Becerra-Massare P; López de la Torre-Casares M; Villar-del Moral J; Céspedes-Mas S; Vílchez-Joya R; Muros-de Fuentes T; García-Calvente C; Piédrola-Maroto G; López-Nevot MA; Montes-Ramírez R; Llamas-Elvira JM
    Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma.
    Yano Y; Uematsu N; Yashiro T; Hara H; Ueno E; Miwa M; Tsujimoto G; Aiyoshi Y; Uchida K
    Clin Cancer Res; 2004 Mar; 10(6):2035-43. PubMed ID: 15041723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma.
    Takano T; Miyauchi A; Yoshida H; Kuma K; Amino N
    Cancer Lett; 2005 Feb; 219(1):91-6. PubMed ID: 15694668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A panel of four genes accurately differentiates benign from malignant thyroid nodules.
    Wang QX; Chen ED; Cai YF; Li Q; Jin YX; Jin WX; Wang YH; Zheng ZC; Xue L; Wang OC; Zhang XH
    J Exp Clin Cancer Res; 2016 Oct; 35(1):169. PubMed ID: 27793213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer.
    Xing M; Tufano RP; Tufaro AP; Basaria S; Ewertz M; Rosenbaum E; Byrne PJ; Wang J; Sidransky D; Ladenson PW
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2867-72. PubMed ID: 15181070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells.
    De Santis E; Di Vito M; Perrone GA; Mari E; Osti M; De Antoni E; Coppola L; Tafani M; Carpi A; Russo MA
    Biomed Pharmacother; 2013 Feb; 67(1):7-16. PubMed ID: 23089475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
    Zhao H; Li H
    Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel procedure for preoperative diagnosis of papillary thyroid carcinoma].
    Man'kovskaia SV; Rekenchinskaia NV; Demidchik IuE; Saenko VA; Iamasita S
    Vopr Onkol; 2007; 53(5):535-7. PubMed ID: 18154116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the PIK3CA gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma?
    Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Dedecjus M; Lewinski A
    Neuro Endocrinol Lett; 2011; 32(1):59-63. PubMed ID: 21407159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.